Ryan MacDonald
Stock Analyst at Needham
(0.05)
# 4,760
Out of 5,043 analysts
615
Total ratings
37.8%
Success rate
-11.3%
Average return
Main Sectors:
Stocks Rated by Ryan MacDonald
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DCGO DocGo | Reiterated: Buy | $3 | $0.3382 | +787.05% | 33 | Sep 30, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $28 | $21.55 | +29.93% | 8 | Sep 11, 2026 | |
| BNED Barnes & Noble Education | Reiterated: Buy | $16 | $12.51 | +27.90% | 28 | Sep 9, 2026 | |
| ODD Oddity Tech | Reiterated: Hold | n/a | $21.11 | - | 5 | Sep 9, 2026 | |
| PHR Phreesia | Reiterated: Buy | $14 | $10.81 | +29.51% | 34 | Sep 3, 2026 | |
| DH Definitive Healthcare | Reiterated: Hold | n/a | $0.98 | - | 24 | Sep 2, 2026 | |
| VEEV Veeva Systems | Reiterated: Buy | $270 → $310 | $296.13 | +4.68% | 33 | Aug 27, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $33 | $26.68 | +23.69% | 5 | Aug 26, 2026 | |
| MH McGraw Hill | Reiterated: Buy | $19 | $13.37 | +42.11% | 9 | Aug 13, 2026 | |
| HIMS Hims & Hers Health | Reiterated: Buy | $35 → $42 | $30.92 | +35.83% | 16 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $41 | $30.50 | +34.43% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $6.56 | +357.32% | 26 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44.19 | $36.13 | +22.31% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.7362 | - | 51 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 | $149.92 | -3.28% | 22 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.70 | - | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $97 | $102.90 | -5.73% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $70.93 | +5.74% | 17 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.16 | +93.80% | 37 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.77 | - | 23 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $6.93 | +44.30% | 30 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $25 | $33.09 | n/a | 32 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $232.22 | n/a | 22 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 → $83 | $65.36 | n/a | 2 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $92 | $263.78 | n/a | 2 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $20 | $7.34 | n/a | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $500 | $228.30 | n/a | 18 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $45.48 | n/a | 17 | Jul 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.32 | n/a | 12 | Jul 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $141.40 | n/a | 3 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $165 | $242.27 | n/a | 4 | Jun 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $78 → $86 | $186.59 | n/a | 5 | Feb 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $229.13 | n/a | 5 | Feb 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $75 | $535.07 | n/a | 5 | Jan 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 → $107 | $140.86 | n/a | 4 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $95 → $80 | $137.18 | n/a | 2 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $30 | $23.25 | n/a | 4 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $190 | $418.78 | n/a | 2 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $43 | $202.42 | n/a | 1 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $7.81 | n/a | 1 | Jul 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $5.8 → $3 | $13.24 | n/a | 4 | Dec 26, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1.5 | $30.43 | n/a | 1 | Mar 6, 2014 |
DocGo
Sep 30, 2026
Reiterated: Buy
Price Target: $3
Current: $0.3382
Upside: +787.05%
Omada Health
Sep 11, 2026
Reiterated: Buy
Price Target: $28
Current: $21.55
Upside: +29.93%
Barnes & Noble Education
Sep 9, 2026
Reiterated: Buy
Price Target: $16
Current: $12.51
Upside: +27.90%
Oddity Tech
Sep 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $21.11
Upside: -
Phreesia
Sep 3, 2026
Reiterated: Buy
Price Target: $14
Current: $10.81
Upside: +29.51%
Definitive Healthcare
Sep 2, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.98
Upside: -
Veeva Systems
Aug 27, 2026
Reiterated: Buy
Price Target: $270 → $310
Current: $296.13
Upside: +4.68%
Waystar Holding
Aug 26, 2026
Reiterated: Buy
Price Target: $33
Current: $26.68
Upside: +23.69%
McGraw Hill
Aug 13, 2026
Reiterated: Buy
Price Target: $19
Current: $13.37
Upside: +42.11%
Hims & Hers Health
Aug 11, 2026
Reiterated: Buy
Price Target: $35 → $42
Current: $30.92
Upside: +35.83%
Aug 7, 2026
Reiterated: Buy
Price Target: $27 → $41
Current: $30.50
Upside: +34.43%
Aug 7, 2026
Reiterated: Buy
Price Target: $30
Current: $6.56
Upside: +357.32%
Aug 7, 2026
Reiterated: Buy
Price Target: $44.19
Current: $36.13
Upside: +22.31%
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.7362
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $145
Current: $149.92
Upside: -3.28%
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $12.70
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: $76 → $97
Current: $102.90
Upside: -5.73%
Jul 31, 2026
Reiterated: Buy
Price Target: $75
Current: $70.93
Upside: +5.74%
Jul 30, 2026
Reiterated: Buy
Price Target: $10
Current: $5.16
Upside: +93.80%
Jul 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.77
Upside: -
Dec 9, 2025
Reiterated: Buy
Price Target: $10
Current: $6.93
Upside: +44.30%
May 2, 2025
Reiterated: Buy
Price Target: $43 → $25
Current: $33.09
Upside: n/a
Nov 1, 2023
Downgraded: Hold
Price Target: n/a
Current: $232.22
Upside: n/a
Jun 20, 2023
Reiterated: Buy
Price Target: $88 → $83
Current: $65.36
Upside: n/a
Jun 20, 2023
Reiterated: Buy
Price Target: $84 → $92
Current: $263.78
Upside: n/a
Feb 28, 2023
Reiterated: Buy
Price Target: $11 → $20
Current: $7.34
Upside: n/a
Nov 3, 2022
Reiterated: Buy
Price Target: $500
Current: $228.30
Upside: n/a
Jul 7, 2021
Rated: Hold
Price Target: n/a
Current: $45.48
Upside: n/a
Jul 7, 2021
Rated: Hold
Price Target: n/a
Current: $5.32
Upside: n/a
Jun 22, 2017
Reiterated: Hold
Price Target: $46
Current: $141.40
Upside: n/a
Jun 21, 2017
Reiterated: Buy
Price Target: $145 → $165
Current: $242.27
Upside: n/a
Feb 28, 2017
Reiterated: Hold
Price Target: $78 → $86
Current: $186.59
Upside: n/a
Feb 27, 2017
Reiterated: Buy
Price Target: $101
Current: $229.13
Upside: n/a
Jan 27, 2017
Reiterated: Buy
Price Target: $70 → $75
Current: $535.07
Upside: n/a
Jan 26, 2017
Reiterated: Buy
Price Target: $95 → $107
Current: $140.86
Upside: n/a
Sep 13, 2016
Downgraded: Hold
Price Target: $95 → $80
Current: $137.18
Upside: n/a
Sep 13, 2016
Initiated Coverage: Buy
Price Target: $23 → $30
Current: $23.25
Upside: n/a
Sep 13, 2016
Initiated Coverage: Buy
Price Target: $190
Current: $418.78
Upside: n/a
Sep 13, 2016
Upgraded: Buy
Price Target: $43
Current: $202.42
Upside: n/a
Jul 7, 2016
Reiterated: Buy
Price Target: $50
Current: $7.81
Upside: n/a
Dec 26, 2014
Upgraded: Hold
Price Target: $5.8 → $3
Current: $13.24
Upside: n/a
Mar 6, 2014
Rated: Buy
Price Target: $1.5
Current: $30.43
Upside: n/a